This drug is beneficial for the treatment of seizures in animal models of genetic mTOR hyperactivation and in patients with tuberous sclerosis complex (TSC) caused by TSC2 or TSC1 mutation leading to mTOR hyperactivation.13, 14. The gene discussed is TSC2; the disease is tuberous sclerosis.